From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases

ConclusionIn this review, we summarize the molecular structure and the action mechanisms of LAG3. Additionally, we highlight its roles in diverse autoimmune diseases and discuss how the manipulation of the LAG3 pathway can serve as a promising therapeutic strategy as well as its specific mechanism with the aim of filling the gaps from bench to bedside.
Source: Inflammation Research - Category: Research Source Type: research